Universal Access and Affordable Medicines
Our campaign promotes transparency, accountability and the public interest in the field of pharmaceuticals. Our evidence-based advocacy aims to guarantee better and affordable medicines for Europe by questioning and reforming the current pharmaceutical business model and calling for better access to medicines for all.
About our work on access to medicines
EPHA joins calls for Treatment Optimization to become a standard step in the development of new medicines in the EU, putting patients at the heart of new developments in research and innovationread more
Analysis & Opinion
Ellen ‘t Hoen of Medicines Law and Policy on why it is time to change the system of pharmaceutical incentives in the EUread more
Get monthly updates on key public health issues!
Time for a new deal
14 November 2019
4th EPHA Universal Access and Affordable Medicines Forum. Challenging the status quo on medicines policy.
Putting health first
3 June 2019
Trailblazers, routes to better and affordable medicines by 2025
20 November 2018
How good are our medicines?
3 October 2018
Game changers for better and affordable medicines in Europe
21 November 2017
Do you have a question?
Meet our Universal Access and Affordable Medicines Policy Lead.
+32 2 233 3886